Institute for Molecular Medicine (EIN 880366979) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Principal Officer

Garth L Nicolson PhD

Phone

7145967821

Tax Period

2022-07-01 to 2023-06-30

Institute for Molecular Medicine, founded in 1996, is a community nonprofit in the Health Care sector that reported $5.4M in total revenue in fiscal year 2022. Revenue decreased 15% compared to the prior year.

Mission

The mission of the Institute for Molecular Medicine is to contribute to the understanding of and the prevention and cure of catastrophic human chronic diseases, such as autoimmune diseases, fatigue illnesses, rheumatic diseases, cancer, AIDS, and infectious and genetic diseases. This will be accomplished through innovative basic and translational reasearch programs.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $5,423,619

Program Service Revenue $0

Investment Income $7

Other Revenue $0

TOTAL REVENUE $5,423,626

Expense Breakdown

Grants Paid $488,542

Salaries & Benefits $1,168,044

Fundraising Expenses $0

Program Expenses $4,550,708

Other Expenses $3,770,094

TOTAL EXPENSES $5,426,680

Year-over-Year Comparison

	2022	2021	Change
Revenue	$5,423,626	$6,390,292	-0.2%
Expenses	$5,426,680	$6,399,709	-0.2%
Net Income	$-3,054	$-9,417	-0.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$375,190

Total Directors

$379,825

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
M Agadjanyan DScPHD	V.Pres/Treas.	40.00	Officer Director	$203,167	$2,023	$205,190
A Ghochikyan PHD	BM & Secretary	40.00	Director	$160,000	$14,635	$174,635
A Agadjanyan	Financial Dir.	30.00	Officer	$170,000	$0	$170,000
G L Nicolson PHD	President	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$5,423,626	$5,426,680	$1,062,294	$-3,054
2022	$6,390,292	$6,399,709	$553,003	$-9,417
2021	$1,873,974	$1,842,407	$648,185	$31,567
2020	$2,509,661	$2,485,114	$564,387	$24,547
2019	$2,142,079	$2,112,691	$476,211	$29,388
2018	$1,586,384	$1,585,062	$471,864	$1,322

Institute for Molecular Medicine